• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
SARS-CoV-2 in Conjunctiva and Tears and Ocular Symptoms of Patients with COVID-19.新型冠状病毒肺炎患者结膜和泪液中的严重急性呼吸综合征冠状病毒2及眼部症状
Vision (Basel). 2021 Oct 22;5(4):51. doi: 10.3390/vision5040051.
2
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.评估 SARS-CoV-2 在中重度 COVID-19 患者泪液中的情况。
Ophthalmology. 2021 Apr;128(4):494-503. doi: 10.1016/j.ophtha.2020.08.029. Epub 2020 Aug 31.
3
Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients.2019冠状病毒病患者泪液及结膜分泌物中严重急性呼吸综合征冠状病毒2型的检测
J Infect Dev Ctries. 2020 Sep 30;14(9):977-981. doi: 10.3855/jidc.13224.
4
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.中国湖北省 2019 年冠状病毒病(COVID-19)患者的眼部表现特征。
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
5
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms.从无眼部症状患者的结膜分泌物中检测到 SARS-CoV-2。
Infection. 2021 Apr;49(2):257-265. doi: 10.1007/s15010-020-01524-2. Epub 2020 Sep 17.
6
Assessment of Coronavirus in the Conjunctival Tears and Secretions in Patients with SARS-CoV-2 Infection in Sohag Province, Egypt.埃及索哈杰省新型冠状病毒肺炎患者结膜泪液及分泌物中冠状病毒的评估
Clin Ophthalmol. 2020 Sep 15;14:2701-2708. doi: 10.2147/OPTH.S270006. eCollection 2020.
7
SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods.SARS-COV-2 病毒载量在 COVID-19 早期症状患者的泪液中的变化:两种不同泪液采样方法的比较。
Int Ophthalmol. 2022 Aug;42(8):2425-2438. doi: 10.1007/s10792-022-02243-3. Epub 2022 Feb 18.
8
Detection of COVID-19 in tears of ICU-admitted patients with SARS-CoV-2 infection.检测 ICU 收治的 SARS-CoV-2 感染患者的泪液中的 COVID-19。
Int Ophthalmol. 2022 Mar;42(3):723-727. doi: 10.1007/s10792-021-01938-3. Epub 2021 Nov 11.
9
Ocular transmission and manifestation for coronavirus disease: a systematic review.眼部传播与冠状病毒病表现:系统综述。
Int Health. 2022 Mar 2;14(2):113-121. doi: 10.1093/inthealth/ihab028.
10
Evaluation and comparison of conjunctival swab polymerase chain reaction results in SARS-CoV-2 patients with and without ocular manifestations.评价和比较有眼部表现和无眼部表现的 SARS-CoV-2 患者的结膜拭子聚合酶链反应结果。
Indian J Ophthalmol. 2021 Aug;69(8):2211-2214. doi: 10.4103/ijo.IJO_587_21.

引用本文的文献

1
The effect of COVID-19 on visual outcome and dry eye after SMILE.新型冠状病毒肺炎对全飞秒激光微小切口基质透镜切除术术后视力预后及干眼的影响
Adv Ophthalmol Pract Res. 2025 Jan 2;5(2):149-155. doi: 10.1016/j.aopr.2025.01.001. eCollection 2025 May-Jun.
2
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses.2019冠状病毒病对眼表健康的影响:感染机制、免疫调节及炎症反应
Viruses. 2025 Jan 6;17(1):68. doi: 10.3390/v17010068.
3
SARS-CoV-2 positivity rates in tear secretions of inpatient COVID-positive individuals in an Indian tertiary care setting.印度一家三级医疗机构中新冠病毒检测呈阳性住院患者泪液分泌物中的新冠病毒2型阳性率。
Indian J Ophthalmol. 2025 Feb 1;73(2):273-279. doi: 10.4103/IJO.IJO_2347_23. Epub 2024 Jul 11.
4
Ocular manifestations of COVID-19: A systematic review of current evidence.新型冠状病毒肺炎的眼部表现:当前证据的系统评价
Prev Med Rep. 2024 Jan 14;38:102608. doi: 10.1016/j.pmedr.2024.102608. eCollection 2024 Feb.
5
Cycle threshold values of SARS-CoV-2 RNA in conjunctival swabs and nasopharyngeal secretions: a comparative study from a tertiary care center in India.眼结膜拭子和鼻咽分泌物中 SARS-CoV-2 RNA 的循环阈值:来自印度一家三级护理中心的比较研究。
Int Ophthalmol. 2024 Feb 8;44(1):29. doi: 10.1007/s10792-024-02976-3.
6
The Characteristics of Ocular Findings and the Presence of SARS-CoV-2 in the Tears of Coronavirus Disease 2019 Patients.2019冠状病毒病患者泪液中的眼部表现特征及严重急性呼吸综合征冠状病毒2型的存在情况
Cureus. 2023 Sep 2;15(9):e44589. doi: 10.7759/cureus.44589. eCollection 2023 Sep.
7
Clinical Characteristics and Outcomes of Endophthalmitis Before and During the COVID-19 Pandemic.COVID-19大流行之前及期间眼内炎的临床特征与转归
J Ophthalmic Vis Res. 2023 Jul 28;18(3):289-296. doi: 10.18502/jovr.v18i3.13777. eCollection 2023 Jul-Sep.
8
Virological and cytological changes in tears and conjunctiva of patients with COVID-19.COVID-19 患者泪液和结膜的病毒学和细胞学变化。
Indian J Ophthalmol. 2023 Jun;71(6):2436-2442. doi: 10.4103/ijo.IJO_2133_22.
9
Covid-19 and its relation to the human eye: transmission, infection, and ocular manifestations.Covid-19 及其与人类眼睛的关系:传播、感染和眼部表现。
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1771-1780. doi: 10.1007/s00417-022-05954-6. Epub 2022 Dec 31.
10
Ocular symptoms in COVID-19 infection: a survey study.新型冠状病毒肺炎感染中的眼部症状:一项调查研究。
J Ophthalmic Inflamm Infect. 2022 Dec 20;12(1):42. doi: 10.1186/s12348-022-00319-w.

本文引用的文献

1
Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?眼药水对新型冠状病毒的抑制作用:一种阻断病毒传播的预防措施?
Microorganisms. 2021 Jul 21;9(8):1550. doi: 10.3390/microorganisms9081550.
2
No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.无秘密藏身之处?在疫区 1145 名住院患者的眼表面均未检出 SARS-CoV-2。
Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1605-1608. doi: 10.1007/s00417-021-05086-3. Epub 2021 Jan 29.
3
Ocular surface manifestation of COVID-19 and tear film analysis.COVID-19 的眼表表现和泪膜分析。
Sci Rep. 2020 Nov 19;10(1):20178. doi: 10.1038/s41598-020-77194-9.
4
Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.2019 年冠状病毒病(COVID-19)的眼部表现:系统评价和荟萃分析。
PLoS One. 2020 Nov 5;15(11):e0241661. doi: 10.1371/journal.pone.0241661. eCollection 2020.
5
Ocular Surface and Conjunctival Cytology Findings in Patients With Confirmed COVID-19.确诊 COVID-19 患者的眼表面和结膜细胞学发现。
Eye Contact Lens. 2021 Apr 1;47(4):168-173. doi: 10.1097/ICL.0000000000000752.
6
Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients.2019冠状病毒病患者泪液及结膜分泌物中严重急性呼吸综合征冠状病毒2型的检测
J Infect Dev Ctries. 2020 Sep 30;14(9):977-981. doi: 10.3855/jidc.13224.
7
Detection of Coronavirus in Tear Samples of Hospitalized Patients With Confirmed SARS-CoV-2 From Oropharyngeal Swabs.在经口咽拭子确诊为SARS-CoV-2感染的住院患者泪液样本中检测冠状病毒
Cornea. 2021 Mar 1;40(3):348-350. doi: 10.1097/ICO.0000000000002562.
8
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.评估 SARS-CoV-2 在中重度 COVID-19 患者泪液中的情况。
Ophthalmology. 2021 Apr;128(4):494-503. doi: 10.1016/j.ophtha.2020.08.029. Epub 2020 Aug 31.
9
Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.SARS-CoV-2 的眼部症状:可能存在眼部传播或病毒脱落的迹象。
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1269-1279. doi: 10.1080/09273948.2020.1799035. Epub 2020 Sep 1.
10
Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review.新型视角下的 SARS-CoV-2 通过眼部表面传播及其在泪液和结膜分泌物中的检测:综述。
Adv Ther. 2020 Oct;37(10):4086-4095. doi: 10.1007/s12325-020-01442-7. Epub 2020 Aug 18.

新型冠状病毒肺炎患者结膜和泪液中的严重急性呼吸综合征冠状病毒2及眼部症状

SARS-CoV-2 in Conjunctiva and Tears and Ocular Symptoms of Patients with COVID-19.

作者信息

Rodríguez-Ares Teresa, Lamas-Francis David, Treviño Mercedes, Navarro Daniel, Cea María, López-Valladares María Jesús, Martínez Laura, Gude Francisco, Touriño Rosario

机构信息

Department of Ophthalmology, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.

Faculty of Medicine, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.

出版信息

Vision (Basel). 2021 Oct 22;5(4):51. doi: 10.3390/vision5040051.

DOI:10.3390/vision5040051
PMID:34698308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8544743/
Abstract

This study investigates the presence of SARS-CoV-2 in conjunctival secretions and tears and evaluates ocular symptoms in a group of patients with COVID-19. We included 56 hospitalized patients with COVID-19 in this cross-sectional cohort study. Conjunctival secretions and tears were collected using flocked swabs and Schirmer strips for SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR). Assessment of ocular surface manifestations included an OSDI (Ocular Surface Disease Index) questionnaire. Patients had been admitted to hospital for an average of 2.4 days (range 0-7) and had shown general symptoms for an average of 7.1 days (range 1-20) prior to ocular testing. Four (7.1%) of 56 conjunctival swabs and four (4%) of 112 Schirmer strips were positive for SARS-CoV-2. The mean E-gene cycle threshold values (Ct values) were 31.2 (SD 5.0) in conjunctival swabs and 32.9 (SD 2.7) in left eye Schirmer strips. Overall, 17 (30%) patients presented ocular symptoms. No association was found between positive ocular samples and ocular symptoms. This study shows that SARS-CoV-2 can be detected on the conjunctiva and tears of patients with COVID-19. Contact with the ocular surface may transmit the virus and preventive measures should be taken in this direction.

摘要

本研究调查了新冠病毒2型(SARS-CoV-2)在结膜分泌物和泪液中的存在情况,并评估了一组新冠肺炎患者的眼部症状。在这项横断面队列研究中,我们纳入了56例住院的新冠肺炎患者。使用植绒拭子和泪液试纸收集结膜分泌物和泪液,用于SARS-CoV-2逆转录聚合酶链反应(RT-PCR)检测。眼表表现的评估包括眼表疾病指数(OSDI)问卷。患者在进行眼部检测前平均住院2.4天(范围0 - 7天),出现一般症状的平均时长为7.1天(范围1 - 20天)。56份结膜拭子中有4份(7.1%)、112条泪液试纸中有4份(4%)的SARS-CoV-2检测呈阳性。结膜拭子中E基因循环阈值(Ct值)的平均值为31.2(标准差5.0),左眼泪液试纸的Ct值平均值为32.9(标准差2.7)。总体而言,17例(30%)患者出现了眼部症状。眼部样本阳性与眼部症状之间未发现关联。本研究表明,在新冠肺炎患者的结膜和泪液中可检测到SARS-CoV-2。与眼表接触可能会传播病毒,应朝此方向采取预防措施。